GL1X · GenesisL1 explorer

MolNFT v1 · #119716 · protein

Crystal structure of the P53 cancer mutant Y220C in complex with a difluorinated derivative of the small molecule stabilizer PHIKAN083

5G4N · Cellular tumor antigen P53: “Crystal structure of the P53 cancer mutant Y220C in complex with a difluorinated derivative of the small…”. X-ray diffraction, 2 ligands (O83, ZN), 5 pockets (best druggability 0.65). MolNFT v1 #119716…

PDB
5G4N
Type
protein
Length
393 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53
UniProt
P04637
Ligands
O83, ZN
Pockets
5 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACellular tumor antigen P53protein19610% helix, 33% strandP04637
BCellular tumor antigen P53protein1978% helix, 33% strandP04637

Ligands and binding sites

  • O83 · 1-[9-(2,2-difluoroethyl)-9H-carbazol-3-yl]-N-methylmethanamine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15020.650.7755empty
21510.430.7519empty
3620.420.8117O83
4690.410.8019O83
5970.370.7521empty

Interfaces

1 interface between chains.

  • A–B · 283 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 5G4N · Crystal structure of the p53 cancer mutant Y220C in complex with a difluorinated… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.